PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Starting a new metabolic path

JBEI researchers develop technique to help metabolic engineering

Starting a new metabolic path
2011-04-24
(Press-News.org) Efforts to engineer new metabolic pathways into microbes for the inexpensive production of valuable chemical products, such as biofuels or therapeutic drugs, should get a significant boost in a new development from the U.S. Department of Energy (DOE)'s Joint BioEnergy Institute (JBEI). Researchers there have successfully demonstrated a technique they call "targeted proteomics" that speeds up and improves the ability to identify and quantify specific proteins within a cell or microorganism.

"Metabolic engineers and synthetic biologists can use our directed proteomic technique to get useful information about protein levels in their organisms, which in turn can be used to direct valuable followup experiments," says Christopher Petzold, chemist and deputy director for proteomics at JBEI, who led this research. "We believe that targeted proteomics is a useful tool that fills a much needed gap in efforts to engineer new metabolic pathways for microbes."

Petzold, who also holds an appointment with the Lawrence Berkeley National Laboratory (Berkeley Lab)'s Physical Biosciences Division, is the corresponding author on a paper describing this research that was published in the journal Metabolic Engineering. The paper is titled "Targeted proteomics for metabolic pathway optimization: Application to terpene production." Coauthoring the paper with Petzold were Alyssa Redding-Johanson, Tanveer Batth, Rossana Chan, Rachel Krupa, Heather Szmidt, Paul Adams, Jay Keasling, Taek Soon Lee and Aindrila Mukhopadhyay.

Metabolic engineering is the practice of altering genes and chemical pathways within a cell or microorganism to increase production of a specific chemical substance. It is fast becoming one of the principal techniques of modern biotechnology for the microbial production of chemicals that are currently derived from non-renewable resources or from natural resources that are limited. Critical to the success of metabolic engineering efforts are techniques that enable researchers to assemble and optimize novel metabolic pathways in microbes. Given that such pathways often involve multiple different factors, performance- hampering problems, such as the abundance of proteins and messenger RNA, or the activity of enzymes, are not always evident simply by measuring the amount of final product obtained.

"Synthetic biologists and metabolic engineers will utilize a variety of analytical methods to identify the parts of a metabolic pathway that limit production," Petzold says. "At the metabolite level, for example, monitoring all pathway intermediates helps identify bottlenecks where further engineering could improve the final product titer. However, pathways that divert intermediates to native processes at the cost of final product formation may disguise the actual location of a bottleneck."

Researchers have tried developing assays to evaluate every intermediate in a given metabolic pathway but this has been a major challenge because intermediates often degrade rapidly or are isomers, and because there are few available standards for such evaluations.

"Engineers are often left to guess at the metabolite levels in parts of the pathway," Petzold says.

Targeted proteomics is based on a variation of mass spectrometry called selected-reaction monitoring (SRM) that can be used to rapidly detect and quantify multiple target proteins within complex protein mixtures, such as those found in cells or microbes. When coupled to liquid chro¬matography (LC),SRM mass spectrometry analysis provides high selectivity and sensitivity through the elimination of background signal and noise even in the most complex mix of proteins. This is made possible by selecting only two points of mass for monitoring - a peptide mass and a specific fragment mass – rather than scanning the entire mass range.

"Carrying out targeted proteomics through SRM mass spectrometry analysis is most useful when quantification of multiple proteins in a single sample is desired," Petzold says. "Working with protein-specific peptides, you can analyze 20 or more targeted proteins in an hour, and entire engineered metabolic pathways can be quantified in a single experiment, something that isn't practical with conventional immunoblot analysis."

Petzold and his co-authors demonstrated the effectiveness of their targeted proteomics technique when they used it to measure protein levels in Escherichia coli that were engineered with yeast proteins to produce amorpha-4,11-diene, a member of the family of plant chemicals known as sesquiterpenes. Strains of E. coli containing a high flux mevalonate pathway have the potential to provide a vast range of high value sesquiterpenes and other isoprenoid-based chemical compounds, which today are typically obtained from petrochemical or plant sources.

"Our analysis identified two mevalonate pathway proteins, mevalonate kinase and phosphomevalonate kinase, both from yeast, as potential bottlenecks," Petzold says. "Codon-optimization of the genes encoding mevalonate kinase and phosphomevalonate kinase, and expression from a stronger promoter led to significantly improved levels of these two proteins and a more than three-fold improvement in the final amorpha-4,11-diene titer, greater than 500 milligrams per liter."

Petzold and his JBEI colleagues are now in the process of implementing "scheduled-SRM," a variation of the SRM mass spectrometry analysis that would allow them to easily detect and quantify 100 proteins in a single experiment that can be completed in less than two hours.



INFORMATION:

This research was supported by JBEI through the DOE Office of Science.

JBEI is one of three Bioenergy Research Centers funded by the U.S. Department of Energy to advance the development of the next generation of biofuels. It is a scientific partnership led by Berkeley Lab and including the Sandia National Laboratories, the University of California campuses of Berkeley and Davis, the Carnegie Institution for Science, and the Lawrence Livermore National Laboratory.

Lawrence Berkeley National Laboratory addresses the world's most urgent scientific challenges by advancing sustainable energy, protecting human health, creating new materials, and revealing the origin and fate of the universe. Founded in 1931, Berkeley Lab's scientific expertise has been recognized with 12 Nobel prizes. The University of California manages Berkeley Lab for the U.S. Department of Energy's Office of Science. For more, visit www.lbl.gov.


[Attachments] See images for this press release:
Starting a new metabolic path

ELSE PRESS RELEASES FROM THIS DATE:

LateRooms.com - Berlin Gets Ready for International Design Festival

2011-04-24
The DMY International Design Festival returns to Berlin with a fresh line-up of exhibitions, workshops and other special events this summer. Running from Wednesday June 1st to Sunday June 5th at the city's Tempelhof Airport site, the annual extravaganza will showcase the latest in contemporary design trends and innovative products. The festival's central exhibition is set to occupy an area of 14,000 sq m in the spacious aircraft hangars of Tempelhof, which ceased operating as a commercial airport in 2008. Now used to host major public events and music festivals, ...

Musical activity may improve cognitive aging

Musical activity may improve cognitive aging
2011-04-24
ATLANTA – A study conducted by Brenda Hanna-Pladdy, PhD, a clinical neuropsychologist in Emory's Department of Neurology, and cognitive psychologist Alicia MacKay, PhD, found that older individuals who spent a significant amount of time throughout life playing a musical instrument perform better on some cognitive tests than individuals who did not play an instrument. The findings were published in the April journal Neuropsychology. While much research has been done to determine the cognitive benefits of musical activity by children, this is the first study to examine ...

Entrepreneurship urged to stimulate the economy

2011-04-24
Los Angeles, CA (APRIL XX, 2011) Economists have been pointing to the growth in entrepreneurship and small business hiring as two ways the US economy can speed the recovery process. In his first ever Facebook town hall meeting, President Obama expanded upon this search for economic solutions as part of the White House's "Startup America" initiative. Recent articles show that researchers not only support these notions, but also break them down for the nation and the world. Current entrepreneurial scholarship offers studies that provide avenues for future research and ...

LateRooms.com - Munich to Welcome Emmylou Harris

2011-04-24
Country music legend Emmylou Harris is due to make a rare appearance in Munich this summer. The 12-time Grammy winner will play at the German city's Philharmonie venue on Sunday June 5th, giving fans a chance to hear songs from her 40-year career in the music industry. Harris is due to release Hard Bargain, her latest studio LP, via Nonesuch Records on April 26th. The album features a new composition called The Road, which recalls the time the songwriter spent playing and recording with her mentor Gram Parsons during the early 1970s. On her official website, ...

Discovery identifies elaborate G-protein network in plants

Discovery identifies elaborate G-protein network in plants
2011-04-24
The most elaborate heterotrimeric G-protein network known to date in the plant kingdom has been identified by Dr. Sona Pandey, principal investigator at the Danforth Plant Science Center. The results of this research are published in the recent article, "An elaborate heterotirmeric G-protein family from soybean expands the diversity of G-protein networks," in the New Phytologist. G-proteins are signaling proteins that direct a plant's response to various environmental signals including abiotic and biotic stresses such as drought and disease resistance. Prior to Dr. ...

USC research shows critical role of placenta in brain development

2011-04-24
Research at the Keck School of Medicine of the University of Southern California's (USC) Zilkha Neurogenetic Institute shows for the first time that the human placenta plays an active role in synthesizing serotonin, paving the way to new treatment strategies that could mitigate health impacts such as cardiovascular disease and mental illness. The groundbreaking findings, conducted with researchers from Vanderbilt University as part of a Silvio Conte Center of Excellence grant from the National Institute of Mental Health, offer conclusive evidence that the placenta provides ...

Drug effective in treating kidney disease in diabetic patients

2011-04-24
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health (NIH) and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology (JASN). Diabetic nephropathy remains the leading cause of end-stage kidney disease (ESKD) in the United States. It is a common complication of diabetes, ...

LateRooms.com - Open de Espana Returns to Barcelona

2011-04-24
It has been more than a decade since Barcelona's Real Club de Golf El Prat hosted the Open de Espana. The competition will make its triumphant return to the Catalan course on May 5th, with many of the top golfing professionals from the European Tour expected to star. As well as the chance to boost their rankings, players are also competing for a prize pot of EUR2 million (GBP1.7 million). The Open de Espana has previously been won by illustrious names such as Sergio Garcia, Padraig Harrington, Colin Montgomerie and Seve Ballesteros. It is one of the oldest tournaments ...

Subset of self-destructive immune cells may selectively drive diabetes

2011-04-24
New research identifies a distinctive population of immune cells that may play a key role in the pathogenesis of diabetes. The research, published by Cell Press and available online in the April 21st issue of Immunity, sheds new light on the pathogenesis of diabetes and may lead to the development of new more selective therapeutic strategies for diabetes and other autoimmune diseases of the accessory organs of the digestive system. Type 1 diabetes (T1D) is a chronic autoimmune disease that develops when the immune system destroys insulin-producing cells in the pancreas. ...

Kidney disease coupled with heart disease common problem in elderly

2011-04-24
Patients on peritoneal dialysis (PD) typically have a higher early survival rate than patients on hemodialysis (HD). New data suggest that this difference may be explained by a higher risk of early deaths among patients undergoing HD with central venous catheters, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). In a study that included more than 38,500 Canadian patients starting dialysis between 2001 and 2008, 63 percent started hemodialysis using a central catheter placed into one of the large veins. Seventeen ...

LAST 30 PRESS RELEASES:

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

[Press-News.org] Starting a new metabolic path
JBEI researchers develop technique to help metabolic engineering